In comparison, anti-PF4 antibodies were detected only in 3 out of the 73 thrombotic APS patients (4.1%) and in none of the 20 obstetric APS patients (0%), respectively. This evidence concerns the gene PF4 and autoimmune polyendocrinopathy.